secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2022-11-25T23:59:59+00:00
Accession:  0001564590-22-038292
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences receives Nasdaq delisting notice for low equity; plans to submit compliance plan
--------------------------------------------------------------------------------

- Stockholders' equity as of Sept 30, 2022 was $1.0M, below Nasdaq's $2.5M minimum.
- Nasdaq gave 45 days (until Jan 6, 2023) to submit a plan to regain compliance.
- Company expects to submit plan citing recent private offering to boost equity.
- If plan accepted, Nasdaq may grant up to 180 days extension; if not, delisting possible.
- No immediate effect on trading; stock continues on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000156459022038292/0001564590-22-038292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000156459022038292/achv-8k_20221122.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-038292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer